Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2009 | 1 |
2010 | 1 |
2012 | 1 |
2013 | 1 |
2014 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Recovering from burnout: Doing a home visit and finding an old friend and an entire community.
S Afr Fam Pract (2004). 2023 May 15;65(1):e1-e2. doi: 10.4102/safp.v65i1.5750.
S Afr Fam Pract (2004). 2023.
PMID: 37265130
Free PMC article.
An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults.
Levie K, Leroux-Roels I, Hoppenbrouwers K, Kervyn AD, Vandermeulen C, Forgus S, Leroux-Roels G, Pichon S, Kusters I.
Levie K, et al. Among authors: forgus s.
J Infect Dis. 2008 Sep 1;198(5):642-9. doi: 10.1086/590913.
J Infect Dis. 2008.
PMID: 18576945
Clinical Trial.
Item in Clipboard
Improved CD4⁺ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial.
Leroux-Roels I, Forgus S, De Boever F, Clement F, Demoitié MA, Mettens P, Moris P, Ledent E, Leroux-Roels G, Ofori-Anyinam O; M72 Study Group.
Leroux-Roels I, et al. Among authors: forgus s.
Vaccine. 2013 Apr 19;31(17):2196-206. doi: 10.1016/j.vaccine.2012.05.035. Epub 2012 May 27.
Vaccine. 2013.
PMID: 22643213
Clinical Trial.
Item in Clipboard
Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
Leroux-Roels I, Roman F, Forgus S, Maes C, De Boever F, Dramé M, Gillard P, van der Most R, Van Mechelen M, Hanon E, Leroux-Roels G.
Leroux-Roels I, et al. Among authors: forgus s.
Vaccine. 2010 Jan 8;28(3):849-57. doi: 10.1016/j.vaccine.2009.10.017. Epub 2009 Oct 14.
Vaccine. 2010.
PMID: 19835828
Clinical Trial.
Item in Clipboard
Community v. non-community assault among adults in Khayelitsha, Western Cape, South Africa: a case count and comparison of injury severity.
Forgus S, Delva W, Hauptfleisch C, Govender S, Blitz J.
Forgus S, et al.
S Afr Med J. 2014 Apr;104(4):299-301. doi: 10.7196/samj.7615.
S Afr Med J. 2014.
PMID: 25118558
Item in Clipboard
Cite
Cite